New drug trial aims to tame rett syndrome symptoms
NCT ID NCT07150013
Summary
This early-stage study is testing a drug called vorinostat to see if it is safe and might help control symptoms of Rett syndrome. Up to 15 girls and young women with Rett syndrome will take the drug at different doses, with each person also getting a placebo for comparison. The main goals are to check for side effects and look for early signs that the drug could improve symptoms like movement, behavior, and seizures.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RETT SYNDROME are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Grupo de Investigación Clínica PECET (GIC-PECET)
Medellín, Colombia
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.